Skip to main content
. 2010 Jun 8;4(6):e705. doi: 10.1371/journal.pntd.0000705

Table 1. Primary VL, relapse VL and PKDL treatment data from Médecins Sans Frontières - Holland clinics in Southern Sudan (1999–2007).

1999 2000 2001 2002 2003 2004 2005 2006 2007 Total
Primary VL 636 346 1,514 1,766 2,620 1,057 456 354 51 8,800
(86.0%) (77.1%) (89.4%) (86.2%) (90.8%) (84.6%) (88.2%) (77.5%) (78.5%) (87.1%)
Relapse VL 31 54 53 132 165 79 25 72 10 621
(4.2%) (12.0%) (3.2%) (6.4%) (5.8%) (6.3%) (4.8%) (15.8%) (15.4%) (6.1%)
PKDL 73 49 126 151 101 113 36 31 4 684
(9.9%) (10.9%) (7.5%) (7.4%) (3.5%) (9.0%) (7.0%) (6.8%) (6.1%) (6.8%)
Total for whom treatment data were entered 740 449 1,693 2,049 2,886 1,249 517 457 65 10,105
(100.0%) (100.0%) (100.0%) (100.0%) (100.0%) (100.0%) (100.0%) (100.0%) (100.0%) (100.0%)
Total number of treatments a 799 540 1,909 2,111 3,414 1,934 1,447 590 180 12,924
Proportion for whom data were entered 92.6% 83.1% 88.7% 97.1% 84.5% 64.6% 35.7% 77.5% 36.1% 78.2%
Proportion of primary VL patients treated in Lankien b 58.4% 45.4% 41.2% 80.9% 80.4% 4.8% 75.0% 76.8% 98.0% 61.4%
a

from MSF summary statistics.

b

low proportion in 2004 due to looting of Lankien and consequent loss of patient medical record.